Company page

Actuate Therapeutics, Inc.

Actuate Therapeutics, Inc. is a public company traded under the ticker ACTU in the American market. The company has a market capitalization of approximately $49.5 million. Actuate Therapeutics focuses on developing innovative therapies to address unmet medical needs.

profileACTU:NASDAQAI content: aiUpdated June 24, 2026/company/actuate-therapeutics-inc-common-stock/c-rfn4kcsx
Actuate Therapeutics, Inc. logo
Ticker
ACTU:NASDAQ
Asset type
Stock
Market cap
$49.5M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD